These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3092309)

  • 1. Immunoglobulin G: potentiation of tobramycin and azlocillin in the treatment of Pseudomonas aeruginosa sepsis in neutropenic mice and neutralization of exotoxin A in vivo.
    Collins MS; Tsay GC; Hector RF; Roby RE; Dorsey JH
    Rev Infect Dis; 1986; 8 Suppl 4():S420-5. PubMed ID: 3092309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy of experimental Pseudomonas burn wound sepsis with ciprofloxacin and Pseudomonas immune globulin.
    Collins MS; Tsay GC; Hector RF; Roby RE; Dorsey JH
    Antibiot Chemother (1971); 1987; 39():222-32. PubMed ID: 3118784
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative efficacy of ciprofloxacin, azlocillin, and tobramycin alone and in combination in experimental Pseudomonas sepsis.
    Johnson M; Miniter P; Andriole VT
    J Infect Dis; 1987 Apr; 155(4):783-8. PubMed ID: 3102631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive immune therapy for experimental Pseudomonas aeruginosa pneumonia in the neutropenic host.
    Pennington JE; Small GJ
    J Infect Dis; 1987 May; 155(5):973-8. PubMed ID: 3104484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of ciprofloxacin, azlocillin, imipenem/cilastatin and tobramycin in a model of experimental septicemia due to Pseudomonas aeruginosa in neutropenic mice.
    Ulrich E; Trautmann M; Krause B; Bauernfeind A; Hahn H
    Infection; 1989; 17(5):311-5. PubMed ID: 2599653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic strategies for Pseudomonas aeruginosa pneumonia in the myelosuppressed host.
    Pennington JE
    Antibiot Chemother (1971); 1987; 39():51-9. PubMed ID: 3118791
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of Pseudomonas aeruginosa exoenzyme expression by subinhibitory antibiotic concentrations.
    Grimwood K; To M; Rabin HR; Woods DE
    Antimicrob Agents Chemother; 1989 Jan; 33(1):41-7. PubMed ID: 2496657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative anti-Pseudomonas aeruginosa activity of chemically modified and native immunoglobulin G (human), and potentiation of antibiotic protection against Pseudomonas aeruginosa and group B Streptococcus in vivo.
    Collins MS; Dorsey JH
    Am J Med; 1984 Mar; 76(3A):155-60. PubMed ID: 6424444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic and therapeutic protection of human IgG purified from sera containing anti-exotoxin A titers against pneumonia caused by
    Zhang J; Wan C; Yu B; Gao C; Zhao L; Cheng X; Yang F; Gu H; Zou Q; Gu J; Wang X
    Hum Vaccin Immunother; 2019; 15(12):2993-3002. PubMed ID: 31116632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs.
    Rusnak MG; Drake TA; Hackbarth CJ; Sande MA
    J Infect Dis; 1984 Jun; 149(6):980-5. PubMed ID: 6429255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of ciprofloxacin alone and in combination with azlocillin in experimental endocarditis due to Pseudomonas aeruginosa.
    Thauvin C; Lecomte F; Le Boete I; Grise G; Lemeland JF
    Infection; 1989; 17(1):31-4. PubMed ID: 2493429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activities of tobramycin and azlocillin alone and in combination against experimental osteomyelitis caused by Pseudomonas aeruginosa.
    Norden CW; Shaffer MA
    Antimicrob Agents Chemother; 1982 Jan; 21(1):62-5. PubMed ID: 6805423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa.
    Collins MS; Roby RE
    Am J Med; 1984 Mar; 76(3A):168-74. PubMed ID: 6424446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacies of alkaline protease, elastase and exotoxin A toxoid vaccines against gut-derived Pseudomonas aeruginosa sepsis in mice.
    Matsumoto T; Tateda K; Furuya N; Miyazaki S; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K
    J Med Microbiol; 1998 Apr; 47(4):303-8. PubMed ID: 9568995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-ETA IgG neutralizes the effects of Pseudomonas aeruginosa exotoxin A.
    Fogle MR; Griswold JA; Oliver JW; Hamood AN
    J Surg Res; 2002 Jul; 106(1):86-98. PubMed ID: 12127813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
    Johnson DE; Thompson B
    Am J Med; 1986 May; 80(5C):53-8. PubMed ID: 3636060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective activity of anti-exotoxin A monoclonal antibody against mice infected with toxin-producing Pseudomonas aeruginosa.
    Kohzuki T; Eguchi Y; Kato M; Irie K; Ohtsuka H; Higuchi A; Noguchi H
    J Infect Dis; 1993 Jan; 167(1):119-25. PubMed ID: 8418158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined host and specific anti-Pseudomonas-directed therapy for Pseudomonas aeruginosa infections in burned mice: experimental results and theoretic considerations.
    Holder IA; Neely AN
    J Burn Care Rehabil; 1989; 10(2):131-7. PubMed ID: 2496130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathogenesis of infections owing to Pseudomonas aeruginosa using the burned mouse model: experimental studies from the Shriners Burns Institute, Cincinnati.
    Holder IA
    Can J Microbiol; 1985 Apr; 31(4):393-402. PubMed ID: 3924388
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of ciprofloxacin with azlocillin plus tobramycin in the therapy of experimental Pseudomonas aeruginosa endocarditis.
    Strunk RW; Gratz JC; Maserati R; Scheld WM
    Antimicrob Agents Chemother; 1985 Sep; 28(3):428-32. PubMed ID: 2934021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.